Skip to main content
  • Long-Term Outcomes of COVID-19-Associated ST-Elevation Myocardial Infarction Treated With Primary PCI

    1. Introduction

    Coronavirus disease 2019 (COVID-19) is known to significantly increase the risk of arterial thrombosis (1*). In patients with type I or ST-elevation myocardial infarction (STEMI) who have COVID-19 infection there is data to suggest a poorer in-hospital outcome compared with patients who are COVID negative and suffer from STEMI (with higher thrombus burden, increased incidence of delayed presentation, cardiogenic shock, left ventricular (LV) dysfunction and need for intensive care) [1], [2], [3], [4], [5]. However, there is a paucity of comparative long-term outcome data in this cohort of patients. Here we examine the characteristics and long terms outcomes of a cohort of COVID positive STEMI patients treated with primary percutaneous coronary intervention (PCI) comparing long-term outcomes with a COVID negative group from the first and second waves of the pandemic.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details